These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1829022)

  • 21. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil.
    Djazayeri K; Szilvássy Z; Benko K; Rózsa B; Szabó B; Szentmiklósi AJ; Benko I
    Pharmacol Res; 2006 Feb; 53(2):156-61. PubMed ID: 16338143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian rhythm and 5-fluorouracil toxicity in C3H mice.
    Popovic P; Popovic V; Baughman J
    Prog Clin Biol Res; 1982; 107():185-7. PubMed ID: 7167477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of systemic antibodies against intestinal Escherichia coli in the prevention of bacterial translocation of Escherichia coli in a burn model in mice.
    Dijkstra HM; Apperloo-Renkema HZ; Manson WL; van der Waaij D; Klasen HJ
    J Trauma; 1994 Apr; 36(4):482-5. PubMed ID: 8158706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral immunization against coli enteritis with streptomycin-dependent E. coli. 3. Comparison of the effectivity of vaccines from killed and live streptomycin-dependent EC-O111 B4 bacteria in active mice protection trial as well as by the inhibition of the settling of homologous streptomycin-resistant strain in the "sterile intestine" of mice].
    Linde K; Koch H
    Zentralbl Bakteriol Orig; 1969; 211(4):476-85. PubMed ID: 4916988
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of a nonapeptide thymic hormone on intestinal intraepithelial lymphocytes in mice following administration of 5-fluorouracil.
    Inagaki-Ohara K; Kobayashi N; Nishimura H; Sakai T; Matsumoto Y; Hiromatsu K; Awaya A; Yoshikai Y
    Cell Immunol; 1996 Jul; 171(1):30-40. PubMed ID: 8660834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
    Sekiguchi I; Suzuki M; Tamada T; Nishida M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil.
    McQuade RM; Stojanovska V; Donald E; Abalo R; Bornstein JC; Nurgali K
    Neurogastroenterol Motil; 2016 Dec; 28(12):1861-1875. PubMed ID: 27353132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.
    Malet-Martino M; Martino R
    Oncologist; 2002; 7(4):288-323. PubMed ID: 12185293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of host defense by a unicellular green alga, Chlorella vulgaris, to Escherichia coli infection.
    Tanaka K; Koga T; Konishi F; Nakamura M; Mitsuyama M; Himeno K; Nomoto K
    Infect Immun; 1986 Aug; 53(2):267-71. PubMed ID: 3015799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury.
    Zhang S; Liu Y; Xiang D; Yang J; Liu D; Ren X; Zhang C
    Biomed Pharmacother; 2018 Oct; 106():910-916. PubMed ID: 30119262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
    Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
    Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal toxicities of 5-fluorouracil increase the proportion of regulatory T cells in intestinal tract: advantages of alternate-day S-1 administration.
    Kajiwara T; Miura K; Ohnuma S; Shimada M; Komura T; Toshima M; Kohyama A; Kudoh K; Haneda S; Musha H; Naitoh T; Shirasaka T; Unno M
    Int J Clin Oncol; 2015 Oct; 20(5):913-21. PubMed ID: 25652909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian variation of 5-fluorouracil and cis-platinum toxicity in mice.
    Shakil A; Hirabayashi N; Toge T
    Hiroshima J Med Sci; 1993 Dec; 42(4):147-54. PubMed ID: 8014066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
    Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.
    O'Hanley P; Lark D; Falkow S; Schoolnik G
    J Clin Invest; 1985 Feb; 75(2):347-60. PubMed ID: 2857730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)].
    Akimoto M; Ueki H; Nakajima Y; Matano S; Ewasaki H; Abe R; Kasai M
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1462-7. PubMed ID: 6204597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.
    Koyama F; Fujii H; Mukogawa T; Ueno M; Hamada H; Ishikawa H; Doi S; Nakao T; Matsumoto H; Shimatani H; Takeuchi T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1343-8. PubMed ID: 12820392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse model for acute bacterial prostatitis in genetically distinct inbred strains.
    Elkahwaji JE; Ott CJ; Janda LM; Hopkins WJ
    Urology; 2005 Oct; 66(4):883-7. PubMed ID: 16230175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.